Retraction. The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.

Retraction. The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4169477?pdf=render

Similar Items

The effect of soluble RAGE on inhibition of angiotensin II-mediated atherosclerosis in apolipoprotein E deficient mice.
by: Dajeong Lee, et al.
Published: (2013-01-01)

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice.
by: Polyxeni T Mantani, et al.
Published: (2015-01-01)

Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-deficient mice.
by: Jun Liu, et al.
Published: (2014-01-01)

The Protective Effect of Bosentan against Atherosclerosis in Apolipoprotein E-Deficient Mice Is Mediated by miRNA-21
by: Xiaona Xu, et al.
Published: (2019-01-01)

CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice
by: Juying Han, et al.
Published: (2018-04-01)

Effects of high density lipoproteins on the progression of atherosclerosis in apolipoprotein E-deficient mice
by: Choudhury, Robin P.
Published: (2002)

Deficiency of LMP10 Attenuates Diet-Induced Atherosclerosis by Inhibiting Macrophage Polarization and Inflammation in Apolipoprotein E Deficient Mice
by: Jiawei Liao, et al.
Published: (2020-10-01)

Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E–deficient mice
by: Jiqu Xu, et al.
Published: (2018-07-01)

Homozygous disruption of Pctp modulates atherosclerosis in apolipoprotein E-deficient mice
by: Wen-Jun Wang, et al.
Published: (2006-11-01)

Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
by: Karen Alejandra Méndez-Lara, et al.
Published: (2020-11-01)

Cholesterol-lowering pattern affects the progression of atherosclerosis in apolipoprotein E deficient mice
by: Yusuke Masuda, et al.
Published: (2016-12-01)

Mineralocorticoid receptor blockade inhibits accelerated atherosclerosis induced by a low sodium diet in apolipoprotein E-deficient mice
by: Ayelet Raz-Pasteur, et al.
Published: (2014-09-01)

Adiponectin receptor 2 deficiency results in reduced atherosclerosis in the brachiocephalic artery in apolipoprotein E deficient mice.
by: Anna Lindgren, et al.
Published: (2013-01-01)

Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice
by: Fei Zheng, et al.
Published: (2014-01-01)

Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E–deficient mice
by: Xiaokun Guo, et al.
Published: (2019-01-01)

Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis
by: Cong-Lin Liu, et al.
Published: (2017-04-01)

Radiological assessment of effectiveness of soluble RAGE in attenuating Angiotensin II-induced LVH mouse model using in vivo 9.4T MRI
by: Dan Heo, et al.
Published: (2019-06-01)

Hepatic overexpression of methionine sulfoxide reductase A reduces atherosclerosis in apolipoprotein E-deficient mice
by: Yan-Yong Xu, et al.
Published: (2015-10-01)

Resveratrol protects against diet-induced atherosclerosis by reducing low-density lipoprotein cholesterol and inhibiting inflammation in apolipoprotein E-deficient mice
by: Geng-Ruei Chang, et al.
Published: (2015-11-01)

Equol Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice by Inhibiting Endoplasmic Reticulum Stress via Activation of Nrf2 in Endothelial Cells.
by: Ting Zhang, et al.
Published: (2016-01-01)

Apolipoprotein E deficiency accelerates atherosclerosis development in miniature pigs
by: Bin Fang, et al.
Published: (2018-10-01)

Activation of CREB Protein With Tabersonine Attenuates STAT3 During Atherosclerosis in Apolipoprotein E-Deficient Mice
by: Sen Shi, et al.
Published: (2020-03-01)

RNA interference of myocyte enhancer factor 2A accelerates atherosclerosis in apolipoprotein E-deficient mice.
by: Wen-ping Zhou, et al.
Published: (2015-01-01)

Yirui Capsules Alleviate Atherosclerosis by Improving the Lipid Profile and Reducing Inflammation in Apolipoprotein E-Deficient Mice
by: Jiqu Xu, et al.
Published: (2018-01-01)

RAGE ligands stimulate angiotensin II type I receptor (AT1) via RAGE/AT1 complex on the cell membrane
by: Serina Yokoyama, et al.
Published: (2021-03-01)

A new synthetic FGF receptor antagonist inhibits arteriosclerosis in a mouse vein graft model and atherosclerosis in apolipoprotein E-deficient mice.
by: Frédérique Dol-Gleizes, et al.
Published: (2013-01-01)

Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice.
by: A C Liu, et al.
Published: (1994-12-01)

Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice.
by: Sofia Xanthoulea, et al.
Published: (2009-01-01)

Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis.
by: Jihwa Chung, et al.
Published: (2016-01-01)

Biochemical Evidence of Atherosclerosis Progression Mediated by Increased Oxidative Stress in Apolipoprotein E–Deficient Spontaneously Hyperlipidemic Mice Exposed to Chronic Cigarette Smoke
by: Masaru Kunitomo, et al.
Published: (2009-01-01)

I-κB kinase-ε knockout protects against angiotensin II induced aortic valve thickening in apolipoprotein E deficient mice
by: Shuai He, et al.
Published: (2019-01-01)

Microarray gene expression profiling reveals antioxidant-like effects of angiotensin II inhibition in atherosclerosis
by: Joshua eAbd Alla, et al.
Published: (2013-06-01)

RAGE deficiency predisposes mice to virus-induced paucigranulocytic asthma
by: Jaisy Arikkatt, et al.
Published: (2017-01-01)

Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility
by: Li Jing, et al.
Published: (2011-12-01)

Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis.
by: Caroline M W van Stijn, et al.
Published: (2014-01-01)

Efficacy of Terpenoid in Attenuating Aortic Atherosclerosis in Apolipoprotein-E Deficient Mice: A Meta-Analysis of Animal Studies
by: Han Liu, et al.
Published: (2019-01-01)

Oral rapamycin attenuates atherosclerosis without affecting the arterial responsiveness of resistance vessels in apolipoprotein E-deficient mice
by: A.L.N. Gadioli, et al.
Published: (2009-12-01)

Intramuscular gene transfer of apolipoprotein E (ApoE) to reverse hyperlipidaemia and atherosclerosis in ApoE-deficient mice
by: Evans, Vanessa
Published: (2007)

Oral administration of the β-glucan produced by Aureobasidium pullulans ameliorates development of atherosclerosis in apolipoprotein E deficient mice
by: Shiho Aoki, et al.
Published: (2015-10-01)

Danlou Tablets Inhibit Atherosclerosis in Apolipoprotein E-Deficient Mice by Inducing Macrophage Autophagy: The Role of the PI3K-Akt-mTOR Pathway
by: Chunping Liu, et al.
Published: (2021-09-01)